Why the study?
How do trends in benzodiazepine prescribing compare among older adults in the VA, Medicare, and commercial insurance systems?
How do trends in benzodiazepine prescribing compare among older adults in the VA, Medicare, and commercial insurance systems?
The VA health system has achieved greater reductions in benzodiazepine prescribing to older adults compared to Medicare and commercial insurance, suggesting other systems could learn from VA strategies.
VA BZD declines may inform non-VA systems; observational data leave open replicability and causality.
BZD prescribing has declined much more to older adults receiving care through the VA than Medicare or commercial insurance. Other systems may learn from strategies implemented in the VA.
No takes yet. Share an insight, caveat, or question.
Maust et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: